- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04309331
Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute
March 12, 2020 updated by: Dr. Schär AG / SPA
Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute (Dr Schär Medical Nutrition - Mevalia Amino Acids) Mevalia PKU Motion 10 - Tropical or Red Fruits Mevalia PKU Motion 20 - Tropical or Red Fruits
The aim of this study is to demonstrate that a new protein substitute is acceptable and well tolerated in children with PKU.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Birmingham, United Kingdom, B4 6NH
- Birmingham Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 16 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of PKU or PKU variant requiring a phenylalanine-free protein substitute
- Subjects who are already taking a phenylalanine-free protein substitute and are willing to try the study product for 7 days
- Patients aged 3 years of age to adulthood
- Written informed consent obtained from parental caregiver
Exclusion Criteria:
- Presence of serious concurrent illness
- Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
- Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.
- Any patients having taken antibiotics over the previous 2 weeks leading up to the study.
- Patients less than 3 years of age.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: PKU Motion
amino acid based protein substitute
|
Amino acid based protein substitute
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastrointestinal tolerance
Time Frame: 7 days
|
Questionnaire detailing any GI symptoms, severity and change from usual • The collection of daily data about the gastro-intestinal tolerance of the protein substitute. |
7 days
|
Product compliance
Time Frame: 7 days
|
Daily questionnaire on amounts offered and amounts actually consumed, compared to recommended amount.
|
7 days
|
Product palatability
Time Frame: 7 days
|
Questionnaire data captured to evaluate taste
|
7 days
|
Product acceptability
Time Frame: 7 days
|
Brief tick-box questionnaire on overall liking and acceptability of product
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2018
Primary Completion (ACTUAL)
September 19, 2018
Study Completion (ACTUAL)
September 19, 2018
Study Registration Dates
First Submitted
February 13, 2020
First Submitted That Met QC Criteria
March 12, 2020
First Posted (ACTUAL)
March 16, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 16, 2020
Last Update Submitted That Met QC Criteria
March 12, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Motion1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Phenylketonurias
-
PTC TherapeuticsNot yet recruitingPhenylketonuriaUnited States
-
First Affiliated Hospital Bengbu Medical CollegeRecruiting
-
Vitaflo International, LtdBirmingham Women's and Children's NHS Foundation TrustRecruiting
-
Jnana TherapeuticsRecruitingPhenylketonuriaUnited States, Australia
-
University Medical Centre LjubljanaNot yet recruitingPhenylketonurias | Nutritional and Metabolic Diseases
-
SynlogicTerminatedPhenylketonuriaUnited States, Canada, Georgia, Turkey
-
University of Southern CaliforniaNational PKU AllianceActive, not recruitingPhenylketonuriasUnited States
-
Boston Children's HospitalBioMarin PharmaceuticalCompletedPhenylketonuriasUnited States
-
University of NebraskaCompleted
Clinical Trials on Motion
-
UConn HealthDonaghue Medical Research FoundationCompleted
-
University of California, DavisCompleted
-
MEDIGREIF Inselklinik HeringsdorfFraunhofer Institut für Graphische Datenverarbeitung (IGD), Rostock, GermanyCompleted
-
University of RostockCompletedOsteoarthritis | Total Knee ArthroplastyGermany
-
Ned AmendolaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Washington University School of MedicineNeurolutions, Inc.TerminatedHemiparesis | Chronic StrokeUnited States
-
Istanbul UniversityCompleted
-
University Hospital, LilleRecruiting